Reuters

U.S. appeals court won't revive Zofran birth defect cases against GSK

1st Circuit says federal law preempts state-law claims over Zofran risks Plaintiffs claimed GSK marketed Zofran for off-label uses Jan 9 - A federal appeals court on Monday declined to revive hundreds ...
Courthouse News Service

Zofran birth-defect lawsuit rejected by First Circuit

BOSTON (CN) — More than 400 families whose children suffered birth defects after their mothers were prescribed Zofran for morning sickness lost their lawsuit Monday against the drug’s manufacturer.
The Daily Record (Maryland)

Plaintiffs in birth defects case stuck with $430K in costs for copying bills

A Massachusetts federal judge has decided that plaintiffs in multidistrict litigation over claims that the anti-nausea drug Zofran caused birth defects must pay GlaxoSmithKline $429,000 for costs ...
Reuters

GSK renews Zofran birth defect dismissal bid after Supreme Court ruling

GlaxoSmithKline PLC says the U.S. Supreme Court's recent ruling on how federal law can preempt state law product liability claims against drugmakers justifies delaying the first trial in lawsuits ...
Nasdaq

U.S. appeals court won't revive Zofran birth defect cases against GSK

Jan 9 - A federal appeals court on Monday declined to revive hundreds of lawsuits by women who claim that GlaxoSmithKline Plc failed to warn them that taking the anti-nausea drug Zofran during ...